Paper22909100
Targeted p21WAF1/CIP1 activation by RNAa inhibits hepatocellular carcinoma cells.
Kosaka M and 3 others. Nucleic Acid Ther, 2012. Cited by 39 papers, by iCite.
Cite this record
ConductScience Library. Targeted p21WAF1/CIP1 activation by RNAa inhibits hepatocellular carcinoma cells. Papers, record 22909100. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22909100
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclin-Dependent Kinase Inhibitor p21 | Major topic |
| RNA, Double-Stranded | Major topic |
| Transcriptional Activation | Major topic |
| Apoptosis | |
| Carcinoma, Hepatocellular | |
| Caspase 3 | |
| Cell Cycle Checkpoints | |
| Cell Proliferation | |
| Cell Survival | |
| Hep G2 Cells | |
| Humans |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 1R01GM090293-0109 | NIGMS NIH HHS | United States | R01GM090293 | PubMed and NIH | NIH RePORTER |
| 1R21CA131774 | NCI NIH HHS | United States | R21CA131774 | PubMed and NIH | NIH RePORTER |
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15466931 | A novel apoptosis pathway activated by the carboxyl terminus of p21. | Blood | 2005 | https://conductscience.org/library/papers/15466931 | PubMed |
| 2 | 17538933 | Restoration of p53 function: a new therapeutic strategy to induce tumor regression? | Hepatology | 2007 | https://conductscience.org/library/papers/17538933 | PubMed |
| 3 | 18765544 | Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action. | Clin Cancer Res | 2008 | https://conductscience.org/library/papers/18765544 | PubMed |
| 4 | 18350603 | Tumor suppressor and hepatocellular carcinoma. | World J Gastroenterol | 2008 | https://conductscience.org/library/papers/18350603 | PubMed |
| 5 | 23343884 | Formulation of Small Activating RNA Into Lipidoid Nanoparticles Inhibits Xenograft Prostate Tumor Growth by Inducing p21 Expression. | Mol Ther Nucleic Acids | 2012 | https://conductscience.org/library/papers/23343884 | PubMed |
| 6 | 18299943 | ZM336372, a Raf-1 activator, causes suppression of proliferation in a human hepatocellular carcinoma cell line. | J Gastrointest Surg | 2008 | https://conductscience.org/library/papers/18299943 | PubMed |
| 7 | 22244202 | RNAa-mediated overexpression of WT1 induces apoptosis in HepG2 cells. | World J Surg Oncol | 2012 | https://conductscience.org/library/papers/22244202 | PubMed |
| 8 | 9672255 | Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer. | J Natl Cancer Inst | 1998 | https://conductscience.org/library/papers/9672255 | PubMed |
| 9 | 9584145 | Roles of the tumor suppressor p53 and the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in receptor-mediated apoptosis of WEHI 231 B lymphoma cells. | J Exp Med | 1998 | https://conductscience.org/library/papers/9584145 | PubMed |
| 10 | 20518789 | Double strand RNA-guided endogeneous E-cadherin up-regulation induces the apoptosis and inhibits proliferation of breast carcinoma cells in vitro and in vivo. | Cancer Sci | 2010 | https://conductscience.org/library/papers/20518789 | PubMed |
| 11 | 9418909 | Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. | Mol Cell Biol | 1998 | https://conductscience.org/library/papers/9418909 | PubMed |
| 12 | 17239344 | p21waf1/Cip1 partially mediates apoptosis in hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2007 | https://conductscience.org/library/papers/17239344 | PubMed |
| 13 | 17441809 | Vitamin K2 inhibits the proliferation of HepG2 cells by up-regulating the transcription of p21 gene. | Hepatol Res | 2007 | https://conductscience.org/library/papers/17441809 | PubMed |
| 14 | 19259063 | Development of lipidoid-siRNA formulations for systemic delivery to the liver. | Mol Ther | 2009 | https://conductscience.org/library/papers/19259063 | PubMed |
| 15 | 21159640 | Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. | Cancer Res | 2010 | https://conductscience.org/library/papers/21159640 | PubMed |
| 16 | 11078909 | The p21(cip1/waf1) cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells. | Cancer Lett | 2000 | https://conductscience.org/library/papers/11078909 | PubMed |
| 17 | 20662764 | Defining features and exploring chemical modifications to manipulate RNAa activity. | Curr Pharm Biotechnol | 2010 | https://conductscience.org/library/papers/20662764 | PubMed |
| 18 | 21087528 | p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell. | BMC Cancer | 2010 | https://conductscience.org/library/papers/21087528 | PubMed |
| 19 | 9050992 | p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. | Oncogene | 1997 | https://conductscience.org/library/papers/9050992 | PubMed |
| 20 | 20107511 | RNAa is conserved in mammalian cells. | PLoS One | 2010 | https://conductscience.org/library/papers/20107511 | PubMed |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42796538 | Small Activating RNAs: A Curated Database and an Overview of Rational Design Principles. | Molecules | 2026 | https://conductscience.org/library/papers/42796538 | PubMed |
| 41992232 | Biomimetic proteolipid vesicles delivering small activating RNA to activate the macrophage immunotherapy for the treatment of lung cancer. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41992232 | PubMed |
| 40059188 | Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40059188 | PubMed |
| 39776807 | RNA nanotherapeutics for hepatocellular carcinoma treatment. | Theranostics | 2025 | https://conductscience.org/library/papers/39776807 | PubMed |
| 37416764 | Emerging Progress of RNA-Based Antitumor Therapeutics. | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/37416764 | PubMed |
| 37017558 | Nanotechnology-enabled gene delivery for cancer and other genetic diseases. | Expert Opin Drug Deliv | 2023 | https://conductscience.org/library/papers/37017558 | PubMed |
| 36821623 | p21CIP/WAF1 saRNA inhibits proliferative vitreoretinopathy in a rabbit model. | PLoS One | 2023 | https://conductscience.org/library/papers/36821623 | PubMed |
| 36700046 | Modulating the expression of tumor suppressor genes using activating oligonucleotide technologies as a therapeutic approach in cancer. | Mol Ther Nucleic Acids | 2023 | https://conductscience.org/library/papers/36700046 | PubMed |
| 35367211 | Human constitutive androstane receptor represses liver cancer development and hepatoma cell proliferation by inhibiting erythropoietin signaling. | J Biol Chem | 2022 | https://conductscience.org/library/papers/35367211 | PubMed |
| 33800164 | Small Activating RNAs: Towards the Development of New Therapeutic Agents and Clinical Treatments. | Cells | 2021 | https://conductscience.org/library/papers/33800164 | PubMed |
| 33469364 | GSK-3β Regulates the Expression of P21 to Promote the Progression of Chordoma. | Cancer Manag Res | 2021 | https://conductscience.org/library/papers/33469364 | PubMed |
| 33396739 | Exosomes: Their Role in Pathogenesis, Diagnosis and Treatment of Diseases. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33396739 | PubMed |
| 29804529 | Therapeutic Potential of Small Activating RNAs (saRNAs) in Human Cancers. | Curr Pharm Biotechnol | 2018 | https://conductscience.org/library/papers/29804529 | PubMed |
| 29736305 | RNA activation technique and its applications in cancer research. | Am J Cancer Res | 2018 | https://conductscience.org/library/papers/29736305 | PubMed |
| 29471827 | Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer. | Mol Cancer | 2018 | https://conductscience.org/library/papers/29471827 | PubMed |
| 29212202 | Enhancing E-cadherin expression via promoter-targeted miR-373 suppresses bladder cancer cells growth and metastasis. | Oncotarget | 2017 | https://conductscience.org/library/papers/29212202 | PubMed |
| 28776078 | SaRNA-mediated activation of TRPV5 reduces renal calcium oxalate deposition in rat via decreasing urinary calcium excretion. | Urolithiasis | 2018 | https://conductscience.org/library/papers/28776078 | PubMed |
| 28445988 | Specific up-regulation of p21 by a small active RNA sequence suppresses human colorectal cancer growth. | Oncotarget | 2017 | https://conductscience.org/library/papers/28445988 | PubMed |
| 28123584 | Cigarette smoke extract-induced proliferation of normal human urothelial cells via the MAPK/AP-1 pathway. | Oncol Lett | 2017 | https://conductscience.org/library/papers/28123584 | PubMed |
| 27509128 | miR-6734 Up-Regulates p21 Gene Expression and Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Cells. | PLoS One | 2016 | https://conductscience.org/library/papers/27509128 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 | NCBI Gene |
| CDKN1A | 1026 | PubTator's text mining | https://conductscience.org/library/genes/1026 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22909100
GET https://conductscience.org/api/papers/v1/22909100/references?page=2